Phase 4 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
If you have Type 2 Diabetes:
- You have been diagnosed with type 2 diabetes for at least one year
- You have never used insulin to manage your diabetes
- Your HbA1c (a measure of average blood sugar over time) is between 7.5% and 10% at your screening visit (confirm with trial site)
- Your Body Mass Index (BMI) is 23 or above
If you have Obesity or Overweight without Type 2 Diabetes:
- Your BMI is 30 or above, OR your BMI is 27 or above AND you have already been diagnosed with at least one weight-related health condition such as high blood pressure, a cholesterol or lipid disorder, obstructive sleep apnea, or heart disease
Who may not be able to join:
If you have Type 2 Diabetes:
- You have type 1 diabetes
- You have had a heart attack, stroke, or been hospitalised for heart failure in the last 6 months
- You have been diagnosed with a more severe stage of heart failure (known as Class III or IV congestive heart failure) (confirm with trial site)
- You have type 2 diabetes with severe obesity and are being considered for weight-loss surgery or a similar procedure
If you have Obesity or Overweight without Type 2 Diabetes:
- You have type 1 or type 2 diabetes
- Your body weight has changed by more than 5 kilograms (about 11 pounds) in the last 3 months
- You have previously had, or are planning to have, surgery to treat obesity
- You have had a heart attack, stroke, or been hospitalised for heart failure in the last 6 months
- You have been diagnosed with a more severe stage of heart failure (known as Class III or IV congestive heart failure) (confirm with trial site)
- You have taken any prescription or alternative medicines for weight loss in the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with One or More Serious Adverse Events (SAE) Considered by the Investigator to be Related to Study Drug Administration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.